Initially, Medtronic and Genzyme will work to complete an ongoing 300-patient trial in Europe testing whether injecting skeletal myoblasts into damaged areas of the heart during cardiac bypass surgery helps improve symptoms and reduces hospitalizations in heart failure patients.

FORBES: Using Thigh Muscle To Fix The Heart